Jo E. Lewis
Going Back to the Biology of FGF21: New Insights
Lewis, Jo E.; Ebling, Francis J.P.; Samms, Ricardo J.; Tsintzas, Kostas
Authors
Francis J.P. Ebling
Ricardo J. Samms
Professor KOSTAS TSINTZAS kostas.tsintzas@nottingham.ac.uk
PROFESSOR OF HUMAN PHYSIOLOGY
Abstract
© 2019 Elsevier Ltd Fibroblast growth factor 21 (FGF21) is a protein highly synthesized in the liver that exerts paracrine and endocrine control of many aspects of energy homeostasis in multiple tissues. In preclinical models of obesity and type 2 diabetes, treatment with FGF21 improves glucose homeostasis and promotes weight loss, and, as a result, FGF21 has attracted considerable attention as a therapeutic agent for the treatment of metabolic syndrome in humans. An improved understanding of the biological role of FGF21 may help to explain why its therapeutic potential in humans has not been fully realized. This review will cover the complexities in FGF21 biology in rodents and humans, with emphasis on its role in protection from central and peripheral facets of obesity.
Citation
Lewis, J. E., Ebling, F. J., Samms, R. J., & Tsintzas, K. (2019). Going Back to the Biology of FGF21: New Insights. Trends in Endocrinology and Metabolism, 30(8), 491-504. https://doi.org/10.1016/j.tem.2019.05.007
Journal Article Type | Review |
---|---|
Acceptance Date | May 30, 2019 |
Online Publication Date | Jun 24, 2019 |
Publication Date | Aug 1, 2019 |
Deposit Date | Nov 18, 2019 |
Publicly Available Date | Jun 25, 2020 |
Journal | Trends in Endocrinology & Metabolism |
Print ISSN | 1043-2760 |
Electronic ISSN | 1879-3061 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 30 |
Issue | 8 |
Pages | 491-504 |
DOI | https://doi.org/10.1016/j.tem.2019.05.007 |
Public URL | https://nottingham-repository.worktribe.com/output/3192847 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S1043276019301067 |
Additional Information | This article is maintained by: Elsevier; Article Title: Going Back to the Biology of FGF21: New Insights; Journal Title: Trends in Endocrinology & Metabolism; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.tem.2019.05.007; Content Type: article; Copyright: © 2019 Elsevier Ltd. All rights reserved. |
Contract Date | Nov 18, 2019 |
Files
TEM-D-19-00097 Accepted version
(478 Kb)
PDF
You might also like
Systematic Review: Sarcopenia in paediatric inflammatory bowel disease
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search